Can ceftriaxone induce seizures, and what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftriaxone Can Cause Seizures, Particularly in Renal Impairment

Yes, ceftriaxone can induce seizures and encephalopathy, especially in patients with renal dysfunction—immediately discontinue the drug if neurological symptoms develop and consider dose adjustment or alternative antibiotics in high-risk patients.

Mechanism and Risk Factors

Ceftriaxone-induced neurotoxicity occurs through β-lactam ring interference with GABA neurotransmission, leading to increased excitatory and decreased inhibitory neurotransmitter activity 1. The drug accumulates in cerebrospinal fluid (CSF), with documented concentrations reaching 27.9 mg/L in affected patients 2.

High-risk populations include:

  • Patients with severe renal impairment or end-stage renal disease (ESRD) on hemodialysis 3, 4
  • Elderly patients (reduced clearance) 4
  • Those with pre-existing CNS conditions 1
  • Patients receiving supratherapeutic doses 1

In one documented case, a patient with a solitary kidney had approximately one-tenth normal total body clearance and three times longer elimination half-life, with plasma concentrations reaching 60 μg/mL 4.

Clinical Presentation

Neurological manifestations include:

  • Encephalopathy (confusion, somnolence, lethargy) 1, 3
  • Tonic-clonic seizures 1, 4
  • Myoclonus and jerky movements 3, 5
  • Non-convulsive status epilepticus 1
  • Psychosis 3

Symptoms typically appear after several days of therapy (often 3-8 days) 4, 6.

Immediate Management

When ceftriaxone-induced seizures are suspected:

  1. Discontinue ceftriaxone immediately 1—this is the primary intervention, as symptoms are reversible upon drug cessation 3, 5

  2. Treat active seizures using standard protocols:

    • First-line: Benzodiazepines (lorazepam or midazolam) 7, 8
    • Second-line for refractory seizures: IV valproate, levetiracetam, or fosphenytoin 7, 8
    • The 2024 ACEP guidelines show equivalent efficacy (levetiracetam 47%, fosphenytoin 46%, valproate 49%) for established status epilepticus 8
  3. Consider enhanced elimination in severe cases:

    • Hemoperfusion has been successfully used in hemodialysis patients with ceftriaxone-induced encephalopathy 5
    • Standard hemodialysis does NOT effectively remove ceftriaxone 1
  4. Provide supportive care 1:

    • Airway protection if consciousness impaired
    • Monitor for complications (aspiration, rhabdomyolysis)
    • No specific antidote exists 1

Prevention Strategies

Dose adjustment is critical 1:

  • In patients with both severe renal AND hepatic dysfunction, close clinical monitoring is mandatory 1
  • Standard adult dosing (1-2 g daily) requires NO adjustment for isolated renal or hepatic impairment 1
  • However, in ESRD or severe combined dysfunction, consider dose reduction or alternative antibiotics 4

Alternative antibiotics should be considered in very high-risk patients (ESRD, elderly with CNS disease, prior seizure history).

Important Caveats

  • Plasma drug monitoring cannot predict CSF concentrations due to variable blood-brain barrier penetration 2
  • CSF concentration measurement could confirm diagnosis but is rarely practical 2
  • Symptoms typically resolve within 1 week after discontinuation 5, though fatal outcomes have occurred with delayed recognition 4
  • The Naranjo ADR probability scale can help establish causality (score ≥5 indicates probable drug reaction) 3

Do not confuse ceftriaxone neurotoxicity with other cephalosporin-related complications like immune hemolytic anemia (which presents with jaundice, not seizures) 9 or gallbladder pseudolithiasis 1.

Related Questions

In a patient with persistent fever and a decline in Glasgow Coma Scale to 14/15 while receiving ceftriaxone, and a normal non‑contrast CT brain, what are the likely causes and recommended next diagnostic and therapeutic steps?
After stabilizing the infant following oxygenation, which secondary assessment steps should be performed, including chest X‑ray, evaluation for reversible causes of seizure, and electroencephalogram?
What is the coverage and dosing regimen for Ancef (Cefazolin)?
What is the recommended cefazolin (Ancef) dosing for adults for surgical prophylaxis and infection treatment, including adjustments for renal impairment?
How should I evaluate and manage explosive anger and mood dysregulation in a 20‑year‑old female with a seizure disorder who is taking antiepileptic medication?
What is the appropriate clindamycin dosage for treating an uncomplicated carbuncle in an adult?
What is the appropriate evaluation and management for a patient presenting with a temperature of 39 °C and difficulty swallowing?
What is the appropriate duration of antibiotic therapy for an otherwise healthy adult with uncomplicated acute pyelonephritis?
What is the overall incidence of ceftriaxone‑induced seizures in adult patients, and how does it differ in those with severe renal impairment or on dialysis?
Is it appropriate to send a urine specimen for urinalysis and culture in a patient with a Foley catheter?
What is the ICD‑10‑CM code for vascular dementia (unspecified) in an older adult presenting with slow ambulation, slowed speech, and MRI showing bilateral nonspecific punctate white‑matter hyperintensities due to cerebral small‑vessel disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.